ZA957604B - Injectable liposomal pharmaceutical preparations - Google Patents

Injectable liposomal pharmaceutical preparations

Info

Publication number
ZA957604B
ZA957604B ZA957604A ZA957604A ZA957604B ZA 957604 B ZA957604 B ZA 957604B ZA 957604 A ZA957604 A ZA 957604A ZA 957604 A ZA957604 A ZA 957604A ZA 957604 B ZA957604 B ZA 957604B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparations
phospholipid
liposomal pharmaceutical
injectable liposomal
injectable
Prior art date
Application number
ZA957604A
Other languages
English (en)
Inventor
Hans-Jurgen Hamann
Peter Serno
Matthias Herboth
Peter Kurka
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA957604B publication Critical patent/ZA957604B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y10S977/907—Liposome
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Glass Compositions (AREA)
ZA957604A 1994-09-12 1995-09-11 Injectable liposomal pharmaceutical preparations ZA957604B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4432378A DE4432378A1 (de) 1994-09-12 1994-09-12 Injizierbare liposomale Arzneizubereitungen

Publications (1)

Publication Number Publication Date
ZA957604B true ZA957604B (en) 1996-04-15

Family

ID=6527981

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957604A ZA957604B (en) 1994-09-12 1995-09-11 Injectable liposomal pharmaceutical preparations

Country Status (28)

Country Link
US (1) US5653998A (da)
EP (1) EP0700679B1 (da)
JP (1) JPH0881361A (da)
KR (1) KR960009998A (da)
CN (1) CN1079668C (da)
AT (1) ATE187327T1 (da)
AU (1) AU698441B2 (da)
CA (1) CA2157849A1 (da)
CZ (1) CZ287975B6 (da)
DE (2) DE4432378A1 (da)
DK (1) DK0700679T3 (da)
EE (1) EE03377B1 (da)
ES (1) ES2139800T3 (da)
FI (1) FI954204A (da)
GR (1) GR3032664T3 (da)
HU (1) HUT73808A (da)
IL (1) IL115222A (da)
MY (1) MY111841A (da)
NO (1) NO311556B1 (da)
NZ (1) NZ272943A (da)
PL (1) PL181541B1 (da)
PT (1) PT700679E (da)
RU (1) RU2160099C2 (da)
SI (1) SI0700679T1 (da)
SK (1) SK281611B6 (da)
TW (1) TW359616B (da)
UA (1) UA29469C2 (da)
ZA (1) ZA957604B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
DE19709704C2 (de) 1997-03-10 1999-11-04 Michael Georgieff Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
KR20000003433A (ko) * 1998-06-29 2000-01-15 김영환 반도체소자의 커패시터 제조방법
CA2350430C (en) * 1998-11-13 2008-06-03 Optime Therapeutics, Inc. Method and apparatus for liposome production
JP2003508349A (ja) * 1999-05-14 2003-03-04 エスペリオン エルユーブイ ディベロップメント， インコーポレイテッド アンギナおよび／またはアンギナ等価状態を処置する方法、ならびにそれに関連する薬学的組成物およびキット
DE60123583T2 (de) * 2000-02-04 2007-08-09 Lipoxen Technologies Ltd. Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
US20060177416A1 (en) 2003-10-14 2006-08-10 Medivas, Llc Polymer particle delivery compositions and methods of use
AU2003280505B2 (en) * 2002-06-26 2009-01-15 Syncore Biotechnology Co., Ltd Method of producing a cationic liposomal preparation comprising a lipophilic compound
DE10255195A1 (de) 2002-11-27 2004-06-09 Lipoid Gmbh Micellare wasserlösliche Konzentrate
JP2007522085A (ja) * 2003-06-27 2007-08-09 スミスクライン・ビーチャム・コーポレイション 安定化されたトポテカンリポソーム組成物および方法
US7345093B2 (en) * 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
EP1868571A4 (en) * 2005-03-02 2011-10-26 Univ Northeastern MITOCHONDRIOTROPIC PHOSPHOLIPIDE VESICLES
CA2608631C (en) * 2005-06-09 2014-07-29 Biolipox Ab Method and composition for treating inflammatory disorders
EP1926780B1 (en) 2005-09-22 2013-08-14 Medivas, LLC Bis-( -amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
US8652504B2 (en) 2005-09-22 2014-02-18 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
EP2034961A1 (de) * 2006-06-30 2009-03-18 Gertrud Langhoff Solubilisatformulierungen
JP6081058B2 (ja) * 2009-03-19 2017-02-15 第一三共株式会社 包装により安定保存された固形製剤
US8591942B2 (en) * 2009-09-23 2013-11-26 Indu JAVERI Methods for the preparation of liposomes comprising docetaxel
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
IT1404011B1 (it) 2010-12-03 2013-11-08 Uni Degli Studi Magna Graecia Di Catanzaro Nanovettore coniugato con tsh per il trattamento del cancro della tiroide
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
US9873765B2 (en) 2011-06-23 2018-01-23 Dsm Ip Assets, B.V. Biodegradable polyesteramide copolymers for drug delivery
EP3159368B1 (en) 2011-06-23 2024-07-24 DSM IP Assets B.V. New biodegradable polyesteramide copolymers for drug delivery
FR2979239A1 (fr) * 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol
EP2682106A1 (en) 2012-07-03 2014-01-08 Phares Pharmaceutical Research N.V. Method of solubilizing biologically active compounds
WO2014085914A1 (en) * 2012-12-06 2014-06-12 Misudan Enterprises Inc. Topical liposome compositions containing phenolic anti-inflammatory agents and their methods of preparation
EP3233067B1 (en) 2014-12-18 2019-11-06 DSM IP Assets B.V. Drug delivery system for delivery of acid sensitive drugs
CN110898011B (zh) * 2019-11-27 2022-02-08 西南医科大学 一种依托咪酯纳米制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515335C2 (de) * 1985-04-27 1995-01-26 Bayer Ag Arzneizubereitung enthaltend Dihydropyridine und Verfahren zu ihrer Herstellung
DE4117750A1 (de) * 1991-05-30 1992-12-24 Bayer Ag Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4207481A1 (de) * 1992-03-10 1993-09-16 Bayer Ag Liposomale wirkstoff-formulierungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
ES2139800T3 (es) 2000-02-16
KR960009998A (ko) 1996-04-20
CN1128655A (zh) 1996-08-14
EE03377B1 (et) 2001-04-16
CZ234195A3 (en) 1996-03-13
NZ272943A (en) 1996-07-26
HU9502654D0 (en) 1995-11-28
SK281611B6 (sk) 2001-05-10
DE59507372D1 (de) 2000-01-13
FI954204A (fi) 1996-03-13
PL181541B1 (pl) 2001-08-31
NO311556B1 (no) 2001-12-10
AU698441B2 (en) 1998-10-29
EE9500063A (et) 1996-04-15
NO953578D0 (no) 1995-09-11
HUT73808A (en) 1996-09-30
FI954204A0 (fi) 1995-09-08
NO953578L (no) 1996-03-13
MY111841A (en) 2001-01-31
RU2160099C2 (ru) 2000-12-10
US5653998A (en) 1997-08-05
AU3046495A (en) 1996-03-28
IL115222A (en) 1999-06-20
CN1079668C (zh) 2002-02-27
SI0700679T1 (en) 2000-02-29
PL310344A1 (en) 1996-03-18
PT700679E (pt) 2000-05-31
DE4432378A1 (de) 1996-03-14
JPH0881361A (ja) 1996-03-26
SK112795A3 (en) 1997-02-05
DK0700679T3 (da) 2000-05-29
IL115222A0 (en) 1995-12-31
ATE187327T1 (de) 1999-12-15
GR3032664T3 (en) 2000-06-30
UA29469C2 (uk) 2000-11-15
EP0700679B1 (de) 1999-12-08
CA2157849A1 (en) 1996-03-13
EP0700679A1 (de) 1996-03-13
CZ287975B6 (cs) 2001-03-14
TW359616B (en) 1999-06-01

Similar Documents

Publication Publication Date Title
IL115222A0 (en) Injectable liposomal pharmaceutical preparations
US4956173A (en) Composition and use of ademetionine against ageing of the skin
CA2162993A1 (en) Solid fat nanoemulsions as drug delivery vehicles
EP0742011A4 (en) ABSORBABLE PERCUTANEOUS PREPARATION
CA2133177A1 (en) Rapamycin formulations for oral administration
ES2101574T3 (es) Composicion administrable por via oral apta para formar una microemulsion.
DK0830145T3 (da) Formuleringer omfattende leflunomid
KR970706792A (ko) 수불용성 캄프토테신의 지질 복합체의 동결 건조물(Lyophilizate of lipid complex of water insoluble camptothecins)
ES2086802T3 (es) Formulaciones liposomicas de principios activos y procedimiento para su preparacion.
FI861695A0 (fi) Farmaceutiskt preparat och foerfarande foer administrering daerav.
CA2251656A1 (en) Pharmaceutical compositions containing tyloxapol for administration to the respiratory tract
CA2203566A1 (en) Percutaneously administration preparation
TH20333B (th) สารเตรียมทางยาไลโปโซมอลที่สามารถฉีดได้
US20020058633A1 (en) Compositions based on glycoglyceride and methods of use therefor, in particular cosmetic uses
ES2141049A1 (es) Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
TH20333A (th) สารเตรียมทางยาไลโปโซมอลที่สามารถฉีดได้